We are live on ! Find out more
IOSP icon

Innospec

98.18 USD
+0.53
0.54%
At close Updated Oct 6, 1:08 PM EDT
1 day
0.54%
5 days
1.05%
1 month
5.15%
3 months
19.14%
6 months
35.91%
Year to date
28.71%
1 year
24.58%
5 years
15.33%
10 years
58.46%
 

About: Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.

Employees: 2,450

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 50%
Neutral 42.9%
Negative 7.1%
Neutral
GlobeNewsWire
20 hours ago
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
ENGLEWOOD, Colo., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release third quarter 2026 earnings results on Tuesday, November 3, 2026 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET.
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
Positive
Zacks Investment Research
1 month ago
Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?
Innospec (IOSP) reported earnings 30 days ago. What's next for the stock?
Innospec (IOSP) Up 2% Since Last Earnings Report: Can It Continue?
Positive
Zacks Investment Research
1 month ago
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
The Zacks Chemicals Diversified is expected to benefit from healthy demand across major end-use markets and the end of destocking activities. APD, DD, AVNT and IOSP are set to gain from strategic actions and demand recovery.
4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
Neutral
Seeking Alpha
1 month ago
Innospec: Topline Is Growing As Expected
With the oilfield segment leading topline growth, even more growth should be expected as the adoption of DRA expands and the firm re-enters the Mexico market. In Q2 of 2026, revenue grew 12%, beating estimates by $34.17 million. The firm is now in a better financial position to command a higher sales multiple. The Performance chemical segment still experiences volume declines, raising concerns about the firm over investing by adding 10% capacity in a weak market.
Innospec: Topline Is Growing As Expected
Positive
Zacks Investment Research
2 months ago
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Innospec's Q2 earnings beat estimates as all three businesses delivered revenue growth, while a debt-free balance sheet supports further investment.
IOSP's Q2 Earnings Surpass Estimates on Broad-Based Growth
Positive
Zacks Investment Research
2 months ago
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
Here is how Innospec (IOSP) and Ingevity (NGVT) have performed compared to their sector so far this year.
Is Innospec (IOSP) Stock Outpacing Its Basic Materials Peers This Year?
Neutral
Seeking Alpha
2 months ago
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Innospec Inc. (IOSP) Q2 2026 Earnings Call Transcript
Positive
MarketBeat
2 months ago
Innospec Q2 Earnings Call Highlights
Innospec NASDAQ: IOSP reported higher second-quarter revenue and net income as all three operating segments posted double-digit sales growth and operating-income gains, while the company continued repair and optimization work at its North Carolina Performance Chemicals facilities.
Innospec Q2 Earnings Call Highlights
Positive
Zacks Investment Research
2 months ago
Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates
Innospec (IOSP) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.26 per share a year ago.
Innospec (IOSP) Tops Q2 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
2 months ago
Innospec Reports Second Quarter 2026 Financial Results
Strong contributions from all businesses with revenues up 12 percent and operating income up 16 percent
Innospec Reports Second Quarter 2026 Financial Results
Price charts implemented using Lightweight Charts™